TWO SIGMA INVESTMENTS, LP - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$457,000
+2946.7%
312,833
+2906.6%
0.00%
Q4 2016$15,000
-94.5%
10,405
-75.8%
0.00%
-100.0%
Q1 2014$271,000
+316.9%
43,021
+286.2%
0.00%
Q4 2013$65,000
-49.2%
11,140
-54.2%
0.00%
-100.0%
Q3 2013$128,00024,3290.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 867,700$3,636,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,847,999$24,503,0000.89%
MANGROVE PARTNERS IM, LLC 210,900$884,0000.26%
Lyons Wealth Management, LLC. 56,775$238,0000.25%
Callan Capital, LLC 76,118$319,0000.09%
SABBY MANAGEMENT, LLC 274,782$1,151,0000.04%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 338,703$1,420,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 29,627,959$124,141,0000.03%
Cambridge Investment Research Advisors, Inc. 268,118$1,123,0000.03%
OppenheimerFunds, Inc. 7,000,000$29,330,0000.03%
View complete list of ARENA PHARMACEUTICALS INC shareholders